Evidence map›Paper›PMID 28255555›Full record

ArticleBioMed research international2017

Procalcitonin Impairs Liver Cell Viability and Function In Vitro: A Potential New Mechanism of Liver Dysfunction and Failure during Sepsis?

Martin Sauer, Sandra Doß, Johannes Ehler, Thomas Mencke, Nana-Maria Wagner

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Sepsis and the Liver.Diseases (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Procalcitonin as a Predictive Marker of Incident Liver Disease.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Overview of procalcitonin in pregnancy and in pre-eclampsia.Clinical and experimental immunology · 2019
    Review
  13. Procalcitonin and Liver Disease: A Literature Review.Journal of clinical and translational hepatology · 2019
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Martin SauerClinic for Anesthesiology and Intensive Care Medicine, University Hospital Rostock, Rostock, Germany; Fraunhofer Institute for Cell Therapy and Immunology, EXIM, Rostock, Germany.ORCID 0000-0001-6221-9081
Sandra DoßFraunhofer Institute for Cell Therapy and Immunology, EXIM, Rostock, Germany.ORCID 0000-0001-9727-1605
Johannes EhlerClinic for Anesthesiology and Intensive Care Medicine, University Hospital Rostock, Rostock, Germany.
Thomas MenckeClinic for Anesthesiology and Intensive Care Medicine, University Hospital Rostock, Rostock, Germany.ORCID 0000-0002-9179-4437
Nana-Maria WagnerClinic for Anesthesiology and Intensive Care Medicine, University Hospital Rostock, Rostock, Germany.
University of Rostock · DEFraunhofer Institute for Cell Therapy and Immunology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CalcitoninCell CountCell DeathCell LineCell SurvivalHepatocytesHumansInactivation, MetabolicLiverLiver DiseasesSepsisCalcitonin

Identifiers

PMID28255555
PMCPMC5309405
OpenAlexW2585818916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.